Yahoo Finance19 天
Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial
18, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune ...